India’s ambition to emerge as a global MedTech manufacturing hub is gaining momentum. With a growing domestic healthcare market, expanding manufacturing capabilities, government support and increasing interest from global medical technology companies, the country has many of the ingredients required to become a major force in the sector.
However, the next phase of India’s MedTech journey will require more than assembling medical devices locally. The real opportunity lies in building an ecosystem capable of designing, developing, testing, manufacturing and exporting high-value medical technologies to the world.
India’s medical devices market is projected to grow significantly over the coming years, with industry estimates pointing towards a market of around $50 billion by 2030. Yet, despite this potential, the country continues to rely heavily on imported medical technologies, particularly in high-end and technologically complex segments.
The challenge, therefore, is not simply to increase the number of devices manufactured in India. It is to increase the value created in India.
Moving Beyond Assembly
India has already demonstrated that it can become a competitive manufacturing destination. Its strengths in engineering, pharmaceuticals, information technology and cost-efficient production provide a strong foundation for MedTech manufacturing.
But medical technology manufacturing is fundamentally different from conventional mass manufacturing. A sophisticated medical device depends on a complex ecosystem of precision components, electronics, sensors, software, specialised materials, testing facilities and regulatory expertise.
For India to compete with established MedTech manufacturing centres, localisation needs to extend deeper into the supply chain.
The focus must shift from importing critical components and assembling them domestically to developing indigenous capabilities in component manufacturing, precision engineering and product development. Industry discussions increasingly point to stronger local sourcing and greater domestic value addition as essential to India’s next stage of MedTech growth.
A robust ecosystem of component manufacturers, MSMEs, technology suppliers and specialised engineering companies could play a critical role in making Indian MedTech manufacturing globally competitive.
Innovation Must Become the Centre of Growth
Manufacturing scale alone will not make India a global MedTech leader.
The country must strengthen its ability to create intellectual property and develop technologies that address both domestic and international healthcare needs. This requires closer collaboration between industry, hospitals, research institutions, engineering colleges and start-ups.
Innovation in MedTech is particularly dependent on clinical understanding. Engineers need to work closely with doctors and healthcare professionals to identify unmet needs and develop solutions that can be translated into safe, scalable products.
Recent discussions within the sector have emphasised a shift from simply “Made in India” towards devices that are designed, innovated and exported from India. This reflects the larger transformation required for the sector: from cost-led manufacturing to innovation-led value creation.
India also has an opportunity to develop technologies specifically suited to emerging markets—devices that are affordable, durable, easy to use and capable of operating across diverse healthcare settings.
Strengthening Regulation and Testing Infrastructure
A globally competitive MedTech ecosystem also requires globally credible regulatory and quality infrastructure.
Medical devices must meet rigorous standards of safety, performance and clinical effectiveness. As Indian companies increasingly target international markets, access to advanced testing, validation and certification infrastructure will become even more important.
Strengthening the regulatory ecosystem, reducing unnecessary delays and creating predictable pathways for innovation can help companies bring new technologies to market more efficiently without compromising patient safety.
Recent policy and industry discussions have also highlighted the importance of stronger testing infrastructure and a regulatory framework capable of supporting innovation while maintaining quality standards.
Developing world-class common testing and validation facilities could be particularly valuable for start-ups and smaller manufacturers that may not have the resources to build such infrastructure independently.
Building India Into an Export Hub
India cannot become a global MedTech manufacturing hub by focusing only on its domestic market.
The global medical technology industry presents a significantly larger opportunity, and Indian manufacturers will need to design products with international markets in mind from the beginning. That means understanding global regulatory requirements, building strong quality systems and developing products that can compete on technology—not only price.
India’s large manufacturing base and cost advantages can provide a strong starting point. However, sustainable export growth will depend on reliability, quality, innovation and the ability to integrate Indian companies into global supply chains.
The recent collaboration between Invest India and APACMed reflects the growing focus on attracting investment, increasing local value addition and integrating India more deeply into global MedTech supply chains.
The Road Ahead
Government initiatives, including the National Medical Devices Policy and manufacturing-focused incentive programmes, have created an important policy foundation for the sector. But policy support alone will not create a global hub.
India’s MedTech transformation will require coordinated action across the entire ecosystem—from manufacturers and suppliers to regulators, hospitals, researchers and investors.
The country now has an opportunity to move beyond being a large healthcare market and emerge as a creator of globally relevant medical technologies.
The next chapter of Indian MedTech will not be defined simply by how many devices carry a “Made in India” label. Its real success will depend on how many are conceived, engineered, validated and manufactured in India—and trusted by healthcare systems around the world.
India’s journey towards becoming a global MedTech manufacturing hub has begun. The challenge now is to build the depth, innovation and global competitiveness needed to turn that ambition into a long-term reality.
Source: https://www.thehindubusinessline.com/specials/pulse/what-will-it-take-for-india-to-become-a-global-medtech-manufacturing-hub/article71364069.ece?mrfcid=202608246a8bc48d11a88c72d2ed1ea1